You are here: Home :: Keyword index :: mat bis NAD :: matrix metalloproteinase-9 (MMP-9) - MB microbubbles matrix metalloproteinases

Items for "matrix metalloproteinases"

The insect metalloproteinase inhibitor gene of the lepidopteran Galleria mellonella encodes two distinct inhibitors

The insect metalloproteinase inhibitor (IMPI) from the greater wax moth, Galleria mellonella, represents the first and to date only specific inhibitor of microbial metalloproteinases reported from animals...

Keywords: Galleria mellonella, innate immunity, insects, matrix metalloproteinases, microbial metalloproteinases, protein glycosylation

01/2007 | Biological Chemistry, Walter de Gruyter

“Coelionomics”: towards understanding the molecular pathology of coeliac disease

Coeliac disease (CD) is an inflammatory disorder of the small intestine characterised by a permanent intolerance to gluten-derived peptides...

Keywords: Apoptosis, coeliac disease, matrix metalloproteinases, oxidative stress, proliferation and differentiation

07/2005 | Clinical Chemical Laboratory Medicine, Walter de Gruyter

Matrix metalloproteinases and their inhibitors in different acute stroke subtypes

The aim of the study was to determine serum levels of selected matrix metalloproteinases (MMPs) and their natural inhibitors (TIMPs) in the acute phase of different stroke types subdivided according to the Oxfordshire Community Stroke Project (OCSP) classification and the possibility of discriminating stroke types according to their levels...

Keywords: matrix metalloproteinases, Stroke, tissue inhibitor of metalloproteinases

04/2006 | Clinical Chemical Laboratory Medicine, Walter de Gruyter

Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone disease

Multiple myeloma is characterized by accelerated production of the proteolytic enzyme matrix metalloproteinase (MMP)-9...

Keywords: matrix metalloproteinases, Multiple myeloma, N-telopeptide

09/2005 | Clinical Chemical Laboratory Medicine, Walter de Gruyter

Secretory phospholipase A₂ activity and release kinetics of vascular tissue remodelling biomarkers after coronary artery bypass grafting with and without cardiopulmonary bypass

Background: Cardiopulmonary bypass (CPB) has long been recognised as a main cause of a postoperative complex systemic inflammatory response after coronary artery bypass grafting (CABG).

Methods: We determined the kinetics of peripheral blood release of the novel inflammatory biomarkers secretory phospholipase A₂ (sPLA₂), matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) during the first 6 days following surgery in 16 patients undergoing CABG with (on-pump, n=9) or without (off-pump, n=7) CPB...

Keywords: cardiopulmonary bypass, coronary artery bypass grafting, inflammation, matrix metalloproteinases, phospholipase A2

03/2007 | Clinical Chemical Laboratory Medicine, Walter de Gruyter

Serum levels of the osteoprotegerin, receptor activator of nuclear factor ?-B ligand, metalloproteinase-1 (MMP-1) and tissue inhibitors of MMP-1 levels are increased in men 6 months after acute myocardial infarction

Background: Osteoprotegerin (OPG) and receptor activator of nuclear factor ?-B ligand (RANKL) are critical regulators of bone remodeling and RANKL/RANK signaling could also play an important role in the remodeling process of several tissues, such as myocardium...

Keywords: extracellular matrix, matrix metalloproteinases, myocardial infarction, osteoprotegerin, receptor activator of nuclear factor ?-B ligand, tissue inhibitors of metalloproteinase

04/2008 | Clinical Chemical Laboratory Medicine, Walter de Gruyter

Publisher and Institutes